Colgate-Palmolive shares may be trading at an 8% discount to fair value, according to a widely followed narrative that points to a fair value of $96.68 against a recent close of $89.48. The consumer staples company has returned 15.18% year to date, though its one-year total shareholder return of 4.03% lags longer-term three- and five-year returns of 23.15% and 25.09%. The bullish case rests on productivity and restructuring initiatives worth $200 to $300 million over three years, which are expected to fund innovation, digital, and R&D investments and drive incremental margin expansion. However, the current price-to-earnings ratio of 34.3 times sits above an estimated fair ratio of 21.3 times and a peer average of 21.9 times, suggesting richer pricing and less room for error if growth or margins disappoint.
Colgate-Palmolive CompanyArticle discusses margin expansion narrative from productivity initiatives, suggesting stock is 8% undervalued.